North America Iron Chelation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

October 2017 | 116 pages | ID: N28D6EDF530EN
GlobalInfoResearch

Abstracts

This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is 1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.

Scope of the Report:

This report focuses on the Iron Chelation Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Apotex Inc. (Canada)
• Cipla (India)
• Novartis (Switzerland)
• Sun Pharma (India)
• Natco Pharma (India)

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Deferoxamine
• Deferiprone
• Deferasirox

Market Segment by Applications, can be divided into

• Transfusional Iron Overload
• NTDT Caused Iron Overload

There are 15 Chapters to deeply display the North America Iron Chelation Drug market.

Chapter 1, to describe Iron Chelation Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Iron Chelation Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Iron Chelation Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Iron Chelation Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Iron Chelation Drug Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Iron Chelation Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Deferoxamine
  1.2.2 Deferiprone
  1.2.3 Deferasirox
1.3 Market Analysis by Applications
  1.3.1 Transfusional Iron Overload
  1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Apotex Inc. (Canada)
  2.1.1 Profile
  2.1.2 Iron Chelation Drug Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Apotex Inc. (Canada) News
2.2 Cipla (India)
  2.2.1 Profile
  2.2.2 Iron Chelation Drug Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Cipla (India) News
2.3 Novartis (Switzerland)
  2.3.1 Profile
  2.3.2 Iron Chelation Drug Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Novartis (Switzerland) News
2.4 Sun Pharma (India)
  2.4.1 Profile
  2.4.2 Iron Chelation Drug Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Sun Pharma (India) News
2.5 Natco Pharma (India)
  2.5.1 Profile
  2.5.2 Iron Chelation Drug Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Natco Pharma (India) News

3 NORTH AMERICA IRON CHELATION DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 North America Iron Chelation Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Iron Chelation Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Iron Chelation Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Iron Chelation Drug Manufacturer Market Share
  3.4.2 Top 5 Iron Chelation Drug Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA IRON CHELATION DRUG MARKET ANALYSIS BY COUNTRIES

4.1 North America Iron Chelation Drug Sales Market Share by Countries
4.2 North America Iron Chelation Drug Sales by Countries (2012-2017)
4.3 North America Iron Chelation Drug Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION IRON CHELATION DRUG BY TYPE

5.1 North America Iron Chelation Drug Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Iron Chelation Drug Sales and Market Share by Type (2012-2017)
  5.1.2 North America Iron Chelation Drug Revenue and Market Share by Type (2012-2017)
5.2 Deferoxamine Sales Growth and Price
  5.2.1 North America Deferoxamine Sales Growth (2012-2017)
  5.2.2 North America Deferoxamine Price (2012-2017)
5.3 Deferiprone Sales Growth and Price
  5.3.1 North America Deferiprone Sales Growth (2012-2017)
  5.3.2 North America Deferiprone Price (2012-2017)
5.4 Deferasirox Sales Growth and Price
  5.4.1 North America Deferasirox Sales Growth (2012-2017)
  5.4.2 North America Deferasirox Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION IRON CHELATION DRUG BY APPLICATION

6.1 North America Iron Chelation Drug Sales Market Share by Application (2012-2017)
6.2 Transfusional Iron Overload Sales Growth (2012-2017)
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)

7 UNITED STATES IRON CHELATION DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Iron Chelation Drug Sales and Market Share by Type
7.3 United States Iron Chelation Drug Sales by Application (2012-2017)
7.4 United States Iron Chelation Drug Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Iron Chelation Drug Sales and Market Share by Manufacturer
  7.4.2 United States Iron Chelation Drug Revenue and Market Share by Manufacturer
7.5 United States Iron Chelation Drug Export and Import (2012-2017)

8 CANADA IRON CHELATION DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Iron Chelation Drug Sales and Market Share by Type
8.3 Canada Iron Chelation Drug Sales by Application (2012-2017)
8.4 Canada Iron Chelation Drug Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Iron Chelation Drug Sales and Market Share by Manufacturer
  8.4.2 Canada Iron Chelation Drug Revenue and Market Share by Manufacturer
8.5 Canada Iron Chelation Drug Export and Import (2012-2017)

9 MEXICO IRON CHELATION DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Iron Chelation Drug Sales and Market Share by Type
9.3 Mexico Iron Chelation Drug Sales by Application (2012-2017)
9.4 Mexico Iron Chelation Drug Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Iron Chelation Drug Sales and Market Share by Manufacturer
  9.4.2 Mexico Iron Chelation Drug Revenue and Market Share by Manufacturer
9.5 Mexico Iron Chelation Drug Export and Import (2012-2017)

10 IRON CHELATION DRUG MARKET FORECAST (2017-2022)

10.1 North America Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Iron Chelation Drug Market Forecast by Countries (2017-2022)
  10.2.1 United States Iron Chelation Drug Forecast (2017-2022)
  10.2.2 Canada Iron Chelation Drug Forecast (2017-2022)
  10.2.3 Mexico Iron Chelation Drug Forecast (2017-2022)
10.3 Iron Chelation Drug Market Forecast by Type (2017-2022)
10.4 Iron Chelation Drug Market Forecast by Application (2017-2022)

11 IRON CHELATION DRUG MANUFACTURING COST ANALYSIS

11.1 Iron Chelation Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Iron Chelation Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Iron Chelation Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Iron Chelation Drug Picture
Table Product Specifications of Iron Chelation Drug
Figure North America Sales Market Share of Iron Chelation Drug by Types in 2016
Table Types of Iron Chelation Drug
Figure Deferoxamine Picture
Table Major Manufacturers of Deferoxamine
Figure Deferiprone Picture
Table Major Manufacturers of Deferiprone
Figure Deferasirox Picture
Table Major Manufacturers of Deferasirox
Table North America Iron Chelation Drug Sales Market Share by Applications in 2016
Table Applications of Iron Chelation Drug
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure United States Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Apotex Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table Apotex Inc. (Canada) Iron Chelation Drug Type and Applications
Table Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla (India) Basic Information, Manufacturing Base and Competitors
Table Cipla (India) Iron Chelation Drug Type and Applications
Table Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis (Switzerland) Iron Chelation Drug Type and Applications
Table Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Sun Pharma (India) Iron Chelation Drug Type and Applications
Table Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Natco Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Natco Pharma (India) Iron Chelation Drug Type and Applications
Table Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure North America Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure North America Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table North America Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure North America Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Figure North America Iron Chelation Drug Revenue Market Share by Manufacturer in 2017
Table North America Iron Chelation Drug Price by Manufacturers (2016-2017)
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2016
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2017
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2016
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2017
Figure North America Iron Chelation Drug Sales and Growth (2012-2017)
Table North America Iron Chelation Drug Sales by Countries (2012-2017)
Table North America Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Figure North America 2012 Iron Chelation Drug Sales Market Share by Countries
Figure North America 2016 Iron Chelation Drug Sales Market Share by Countries
Figure North America Iron Chelation Drug Revenue and Growth (2012-2017)
Table North America Iron Chelation Drug Revenue by Countries (2012-2017)
Table North America Iron Chelation Drug Revenue Market Share by Countries (2012-2017)
Table North America 2012 Iron Chelation Drug Revenue Market Share by Countries
Table North America 2016 Iron Chelation Drug Revenue Market Share by Countries
Table North America Iron Chelation Drug Sales by Type (2012-2017)
Table North America Iron Chelation Drug Sales Share by Type (2012-2017)
Table North America Iron Chelation Drug Revenue by Type (2012-2017)
Table North America Iron Chelation Drug Revenue Share by Type (2012-2017)
Figure North America Deferoxamine Sales Growth (2012-2017)
Figure North America Deferoxamine Price (2012-2017)
Figure North America Deferiprone Sales Growth (2012-2017)
Figure North America Deferiprone Price (2012-2017)
Figure North America Deferasirox Sales Growth (2012-2017)
Figure North America Deferasirox Price (2012-2017)
Table North America Iron Chelation Drug Sales by Application (2012-2017)
Table North America Iron Chelation Drug Sales Share by Application (2012-2017)
Figure North America Transfusional Iron Overload Sales Growth (2012-2017)
Figure North America NTDT Caused Iron Overload Sales Growth (2012-2017)
Figure United States Iron Chelation Drug Revenue and Growth (2012-2017)
Figure United States Iron Chelation Drug Sales and Growth (2012-2017)
Table United States Iron Chelation Drug Sales by Type (2012-2017)
Table United States Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table United States Iron Chelation Drug Sales by Application (2012-2017)
Table United States Iron Chelation Drug Sales Market Share by Application (2012-2017)
Table United States Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table United States Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2017
Table United States Iron Chelation Drug Export and Import (2012-2017)
Figure Canada Iron Chelation Drug Revenue and Growth (2012-2017)
Figure Canada Iron Chelation Drug Sales and Growth (2012-2017)
Table Canada Iron Chelation Drug Sales by Type (2012-2017)
Table Canada Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table Canada Iron Chelation Drug Sales by Application (2012-2017)
Table Canada Iron Chelation Drug Sales Market Share by Application (2012-2017)
Table Canada Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure Canada Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure Canada Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table Canada Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure Canada Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Figure Canada Iron Chelation Drug Revenue Market Share by Manufacturer in 2017
Table Canada Iron Chelation Drug Export and Import (2012-2017)
Figure Mexico Iron Chelation Drug Revenue and Growth (2012-2017)
Figure Mexico Iron Chelation Drug Sales and Growth (2012-2017)
Table Mexico Iron Chelation Drug Sales by Type (2012-2017)
Table Mexico Iron Chelation Drug Sales Market Share by Type (2012-2017)
Table Mexico Iron Chelation Drug Sales by Application (2012-2017)
Table Mexico Iron Chelation Drug Sales Market Share by Application (2012-2017)
Table Mexico Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure Mexico Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure Mexico Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table Mexico Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure Mexico Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Figure Mexico Iron Chelation Drug Revenue Market Share by Manufacturer in 2017
Table Mexico Iron Chelation Drug Export and Import (2012-2017)
Figure North America Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)
Table North America Iron Chelation Drug Sales Forecast by Countries (2017-2022)
Table North America Iron Chelation Drug Market Share Forecast by Countries (2017-2022)
Figure United States Iron Chelation Drug Sales Forecast (2017-2022)
Figure Canada Iron Chelation Drug Sales Forecast (2017-2022)
Figure Mexico Iron Chelation Drug Sales Forecast (2017-2022)
Table North America Iron Chelation Drug Sales Forecast by Type (2017-2022)
Table North America Iron Chelation Drug Market Share Forecast by Type (2017-2022)
Table North America Iron Chelation Drug Sales Forecast by Application (2017-2022)
Table North America Iron Chelation Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Iron Chelation Drug
Figure Manufacturing Process Analysis of Iron Chelation Drug
Figure Iron Chelation Drug Industrial Chain Analysis
Table Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016
Table Major Buyers of Iron Chelation Drug
Table Distributors/Traders/ Dealers List